Is Cartalax FDA approved?

Cartalax is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

EGF is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cartalax administered in research settings?

In research settings, Cartalax is typically administered via the subcutaneous or oral routes. PeptideBase does not provide dosing or administration instructions.

How is EGF administered in research settings?

In research settings, EGF is typically administered via the topical, subcutaneous, or microneedling routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cartalax vs EGF

Peptide Comparison

Cartalax vs EGF

Name: Cartalax vs EGF — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Skin & Cosmetic peptides.

Cartalax

Ala-Glu-Asp-Arg

Skin & JointNot EvaluatedResearch Only

Half-life: Unknown

13 providers listed

Full Cartalax profile →

EGF

Epidermal Growth Factor

Skin & JointNot EvaluatedResearch Only

No providers listed yet

Full EGF profile →

Bottom line

EGF has published research citations on file; Cartalax does not yet — the main evidence gap between them.

Quick Verdict

Cartalax

EGF

Which One Should You Choose?

Your goal	Better option
Has published research citations	EGF
Oral administration option	Cartalax
More provider options (13 vs 0)	Cartalax

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cartalax

EGF

Mechanism Family

Skin & Cosmetic

Half-life

Unknown

—

FDA Status

not evaluated

Admin Routes

subcutaneous, oral

topical, subcutaneous, microneedling

Availability

Research Only

Providers

13 listed

None listed

Avail. Notes

Russian joint/cartilage peptide bioregulator (Khavinson Institute). Not FDA-approved. Not on any FDA list. Research chemical in US.

—

Research Evidence

Cartalax

No citations on file

EGF

Review · 2 key studies · most recent 2026

Research Citations

Cartalax

No citations on file.

EGF

In vitro2026 · Gels

Development of Antiseptic and Epidermal Growth Factor Co-Loaded Thermoresponsive Composite Hydrogel for Wound…

Review2026 · Cell Tissue Bank

Determinants of extraction efficiency in human amniotic membrane processing: biological, mechanical, and bioc…

About Cartalax

Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells

Research Areas

cartilage regenerationjoint repairchondrocyte function support

About EGF

Binds EGFR (EGF receptor / ErbB1), activating RAS/MAPK and PI3K/Akt signaling cascades. Promotes keratinocyte and fibroblast proliferation, accelerates wound re-epithelialization, and stimulates collagen and hyaluronic acid production.

Research Areas

skin regenerationwound healingcollagen stimulationpost-procedure recovery

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cartalax

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

EGF

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Price (per mg)

Cartalax

$3.00/mg

$2.70 – $3.41 range

24 vendors

View price index →Find providers →

EGF

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

Cartalax

13 listed

Browse directory →

Providers offering

EGF

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated October 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cartalax vs EGF — Per-mg Price Comparison. Retrieved October 27, 2026, from https://peptidebase.io/peptides/compare/cartalax/egf

https://peptidebase.io/peptides/compare/cartalax/egf Methodology License Download JSON Download CSV